Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Blood|June 5, 2016
Immunoregulatory roles of versican proteolysis in the myeloma microenvironmentChelsea Hope, Simon Foulcer, Justin Jagodinsky, et al.Cancer Immunology Research|May 6, 2015
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple MyelomaJeffrey Lee Jensen, Alexander Rakhmilevich, Erika Heninger, et al.The Journal of Clinical Investigation|December 9, 2014
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesisShi-Dong Ma, Xuequn Xu, Julie Plowshay, et al.The Journal of Biological Chemistry|December 28, 2017
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myelomaMailee Huynh, Chorom Pak, Stephanie Markovina, et al.Scientific Reports|June 23, 2022
Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ modelEvan Flietner, Zhi Wen, Adhithi Rajagopalan, et al.Oncogene|April 8, 2023
Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responsesEvan Flietner, Mei Yu, Govinda Poudel, et al.Blood|April 12, 2014
TPL2 kinase regulates the inflammatory milieu of the myeloma nicheChelsea Hope, Samuel J Ollar, Erika Heninger, et al.Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Single-molecule analysis reveals widespread structural variation in multiple myelomaAditya Gupta, Michael Place, Steven Goldstein, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2017
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal CancerChelsea Hope, Philip B Emmerich, Athanasios Papadas, et al.Cancers|May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8<sup>+</sup> T Cells in Breast CancerPhilip B Emmerich, Tonela Qyli, Katherine A Johnson, et al.Pageof 4